Evidence map›Paper›PMID 34008044›Full record

ArticleInternational journal of hematology2021

Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia.

Yuki Arakawa, Satoshi Masutani, Koichi Oshima, Yuichi Mitani, Makiko Mori, Kohei Fukuoka, Koichi Moriwaki, Motohiro Kato, Katsuaki Taira, Yutaka Tanami and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yuki ArakawaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan. dream98m1089@gmail.com.ORCID http://orcid.org/0000-0003-3001-2240
Satoshi MasutaniDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Koichi OshimaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan.
Yuichi MitaniDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan.
Makiko MoriDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan.
Kohei FukuokaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan.
Koichi MoriwakiDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Motohiro KatoDepartment of Pediatrics, The University of Tokyo, Tokyo, Japan.
Katsuaki TairaDepartment of Orthopedics Surgery, Saitama Children's Medical Center, Saitama, Japan.
Yutaka TanamiDepartment of Radiology, Saitama Children's Medical Center, Saitama, Japan.
Atsuko NakazawaDepartment of Pathology, Saitama Children's Medical Center, Saitama, Japan.
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama, 330-8777, Japan.
Saitama Children's Medical Center · JPSocial Insurance Saitama Chuo Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteonecrosis (ON), a long-term complication of acute lymphoblastic leukemia (ALL) treatment affects patients' quality of life. Although the incidence of any ON, including asymptomatic, was 21.7% among children with ALL in the U.S., the actual incidence and risk factors in Asia remain unknown. For over 11 years, we performed hip magnetic resonance imaging (MRI) screening to detect asymptomatic ON while initiating maintenance chemotherapy in newly diagnosed children with ALL. Overall, 164 of 175 patients underwent hip MRI screening. The incidence of symptomatic or any ON was 3.0% and 11.6%, respectively. Asymptomatic ON in patients < 10 and ≥ 10 years old was 4.0% and 35.9%, respectively (P < 0.001). In multivariate analysis, age ≥ 10 years was the only significant risk factor. Asymptomatic ON with necrosis of > 30% of the epiphyseal surface of the femoral head was detected in four patients (2.4%). All were ≥ 10 years. Three of them progressed to severe symptomatic ON. The incidence of any ON in Asia may be lower than that seen in the only screening study in the U.S. Future studies should clarify factors affecting such regional differences and develop an effective approach to avoid the progression of ON in children with ALL.

Indexed as

Asian PeopleAdolescentAdrenal Cortex HormonesAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolDisease ProgressionDisease SusceptibilityFemaleFemur Head NecrosisHumansIncidenceMagnetic Resonance ImagingMalePatient Outcome AssessmentPrecursor Cell Lymphoblastic Leukemia-LymphomaAdrenal Cortex HormonesHip osteonecrosisMagnetic resonance imaging screeningPediatric leukemia/lymphoma

Identifiers

PMID34008044
OpenAlexW3160079246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.